Click The Pic: Direct to Consumer Healthcare Using Tech

How Alexa’s best skill could be as a home health-care assistant

  • Home health aides are testing the use of Amazon’s Echo platform to assist elderly patients.
  • They are finding this system gives clients more access to family members and assistance to ensure they get their medication on time.
  • Tech companies are rushing to provide similar services.
View Document

Apple healthcare comes under the microscope

It’s unsurprising that Apple has its sights set on the healthcare market. It’s an industry that’s ripe for a tech makeover, and Google, Microsoft, and IBM, among others, are all keen to show that their technology can help with the overhaul.

View Document

Direct to consumer healthcare reduces costs, increases reach

Direct-to-consumer (DTC) telemedicine is growing at an ever-expanding rate due to new phone, computer, app technology and patient demand. Now, patients can quickly assess healthcare providers for phone or video visits via their personal devices. For hospitals and providers, the big draw with virtual visits is the potential savings involved in replacing physician office visits and ER visits.

View Document

Henry Schein Merges its Animal Health with Vets First Choice, Creates Public Company

Upon Completion of the Transaction, Henry Schein Shareholders Will Own Approximately 63%and Vets First Choice Shareholders Will Own Approximately 37% of the New Company; Henry Schein Expects to Receive Between $1.0-1.25 Billion in Cash on a Tax-Free Basis

View Document

Whistle’s ‘Fitbit for dogs’ acquired by Mars Petcare

Whistle, the “Fitbit for dogs,” has found a home at Mars Petcare, TechCrunch has learned. The maker of Snickers and M&M’s also has a large pet division and has plans to integrate Whistle’s animal technology. Mars owns popular pet brands including Pedigree, Whiskas and Iams.

View Document

Mars Petcare Acquisition of OptiGen Will Enable Discovery of New Genetic Health Markers for Dogs

Included in the acquisition are exclusive licenses to a portfolio of genetic disease tests patented in the U.S., Australia and many countries in Europe, and an extensive biobank of more than 150,000 samples collected over 20 years representing various canine eye diseases. Moving forward these samples will be used to discover new genetic health markers for dogs.

View Document

News & Events

View All News
1706, 2019

True Nature Holding Announces UK Acquisition Plan

June 17th, 2019|

ATLANTA, GA / ACCESSWIRE / June 17, 2019 / True Nature Holding, Inc. (OTCQB: TNTY) (the "Company" or "True Nature") announced that it is initiating its European expansion plans with the acquisition of PowerEPOS Ltd. (“EPOS”), www.powerepos.com, a provider of cloud based solutions based in Liverpool, Uni [...]

2205, 2019

True Nature Holding, Inc. Expands Board with Public Equity M&A Exec

May 22nd, 2019|

ATLANTA, GA / ACCESSWIRE / May 22, 2019 / True Nature Holding, Inc. (OTCQB: TNTY) (the "Company" or "True Nature") announced today the appointment of Mr. Douglas Cole to its Board of Directors. Mr. Cole is currently the CEO of American Battery Metals Corporation (ABML), a lithium resource exploration an [...]